ANTIOXIDANT AND ANTIDIABETIC PROPERTIES OF Mondia whitei ROOT EXTRACT IN STREPTOZOTOCIN-INDUCED DIABETIC WISTAR RATS

Abstract

The rising global prevalence of diabetes mellitus (DM) and its complications presents a major health challenge and is exacerbated by the lack of a definitive cure and the side effects of existing treatments, thus, highlighting the need for safer and more sustainable anti-diabetic agents. This study investigated Mondia whitei root extract as an alternative therapeutic option for DM. While traditional medicine suggests that M. whitei possesses antioxidant and anti-diabetic properties, scientific validation is limited. This research aimed to address this gap. Qualitative phytochemicals analysis of crude root extract of M. whitei was done and it’s in vitro antioxidant properties evaluated through 2,2- diphenyl-1-picrylhydrazyl (DPPH) scavenging activity and ferric reducing antioxidant power (FRAP) assays. DM was induced in twenty-four male Wistar rats by a single intraperitoneal injection of 65 mg/Kg body weight (bwt) of streptozotocin (STZ). Animals were randomly assigned to five groups each containing six subjects; Group I (normal control, saline), Group II (diabetic control, saline), Group III (diabetic rats 200 mg/Kg bwt extract treatment), Group IV (diabetic rats 400 mg/Kg bwt extract treatment), and Group V (diabetic rats 100 mg/Kg bwt metformin treatment). Treatments were orally administered for 21 days. Fasting body weights and blood sugar levels were measured weekly. After 21 days, animals were sacrificed and their blood and liver tissue samples collected followed by serum lipid profile, liver and kidney function indices analysis. Liver malondialdehyde (MDA) levels were measured, and liver and plasma’s ferric-reducing capacity were evaluated. Statistical analysis was performed using R software, with paired Student’s t-test and ANOVA determining statistical significance at 95% confidence level. The qualitative phytochemical analysis of the crude M. whitei root extract revealed the presence of saponins, phenols, tannins, alkaloids, flavonoids, glycosides, coumarins, steroids, and terpenoids, while anthraquinones were not detected. The extract significantly scavenged DPPH radical and reduced ferric ions in vitro. M. whitei also showed significant hypoglycemic, hypolipidemic and significantly reduced serum gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT) and alkaline phosphatase (ALP). M. whitei treatment also significantly increased liver and blood plasma capacity to reduce ferric ions as well as protected liver tissues from lipid peroxidation as indicated by significantly reduced levels of MDA. However, M. whitei showed no significant serum urea and creatinine levels decrease. In conclusion, the phytochemical-rich M. whitei root extract demonstrated anti-diabetic, antioxidant, hypolipidemic and hepatoprotective effects in STZ-induced diabetic rats, highlighting its potential as a natural candidate for the management of DM and its complications.